Hepatitis A vaccine response in HIV-infected patients: Are TWINRIX® and HAVRIX® interchangeable?
Highlights ► We assessed the impact of factors on Hepatitis A vaccine response in HIV patients. ► Seroconversion occurred in 54% of the HIV-infected patients receiving Hep A vaccine. ► Responders had higher CD4 counts and lower viral loads than non-responders. ► Viral suppression and vaccine series...
Saved in:
Published in | Vaccine Vol. 31; no. 9; pp. 1328 - 1333 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Kidlington
Elsevier Ltd
18.02.2013
Elsevier Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Highlights ► We assessed the impact of factors on Hepatitis A vaccine response in HIV patients. ► Seroconversion occurred in 54% of the HIV-infected patients receiving Hep A vaccine. ► Responders had higher CD4 counts and lower viral loads than non-responders. ► Viral suppression and vaccine series completion impacted TWINRIX® more than HAVRIX® . ► HAVRIX® and TWINRIX® may not be interchangeable in HIV-infected patients. |
---|---|
Bibliography: | http://dx.doi.org/10.1016/j.vaccine.2012.12.045 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0264-410X 1873-2518 |
DOI: | 10.1016/j.vaccine.2012.12.045 |